Publication Information

{'id': 'https://openalex.org/W2121846636', 'doi': 'https://doi.org/10.1158/2159-8290.cd-13-0226', 'title': 'A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509', 'display_name': 'A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509', 'publication_year': 2013, 'publication_date': '2013-06-19', 'ids': {'openalex': 'https://openalex.org/W2121846636', 'doi': 'https://doi.org/10.1158/2159-8290.cd-13-0226', 'mag': '2121846636', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23779130'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/2159-8290.cd-13-0226', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2486275289', 'display_name': 'Cancer Discovery', 'issn_l': '2159-8274', 'issn': ['2159-8274', '2159-8290'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1158/2159-8290.cd-13-0226', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5037379407', 'display_name': 'James D. Joseph', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James D. Joseph', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035337955', 'display_name': 'Nhin Lu', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nhin Lu', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001637232', 'display_name': 'Jing Qian', 'orcid': 'https://orcid.org/0000-0001-6120-5147'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jing Qian', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006915014', 'display_name': 'John Sensintaffar', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Sensintaffar', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100518237', 'display_name': 'Gang Shao', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gang Shao', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001588458', 'display_name': 'Dan Brigham', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dan Brigham', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110219988', 'display_name': 'Michael Moon', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael Moon', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009723460', 'display_name': 'Edna Chow Maneval', 'orcid': 'https://orcid.org/0000-0001-8131-755X'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Edna Chow Maneval', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063926652', 'display_name': 'Isan Chen', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Isan Chen', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012291117', 'display_name': 'Beatrice Darimont', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Beatrice Darimont', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5079488873', 'display_name': 'Jeffrey H. Hager', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jeffrey H. Hager', 'raw_affiliation_strings': ["Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliation: Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 49.971, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 564, 'citation_normalized_percentile': {'value': 0.999971, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '3', 'issue': '9', 'first_page': '1020', 'last_page': '1029'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11146', 'display_name': 'Hormonal and reproductive studies', 'score': 0.9779, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13157', 'display_name': 'Cancer-related gene regulation', 'score': 0.9407, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.974437}, {'id': 'https://openalex.org/keywords/antiandrogens', 'display_name': 'Antiandrogens', 'score': 0.86045724}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.974437}, {'id': 'https://openalex.org/C2910016293', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogens', 'level': 5, 'score': 0.86045724}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.8274782}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.6775557}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5559655}, {'id': 'https://openalex.org/C75563809', 'wikidata': 'https://www.wikidata.org/wiki/Q2656896', 'display_name': 'Missense mutation', 'level': 4, 'score': 0.54921967}, {'id': 'https://openalex.org/C2779322244', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogen', 'level': 4, 'score': 0.47123063}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.42159602}, {'id': 'https://openalex.org/C501734568', 'wikidata': 'https://www.wikidata.org/wiki/Q42918', 'display_name': 'Mutation', 'level': 3, 'score': 0.382193}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.37829673}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3648315}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.35701305}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.32780844}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.26723313}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.2551825}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.054024726}], 'mesh': [{'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D064129', 'descriptor_name': 'Prostatic Neoplasms, Castration-Resistant', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004247', 'descriptor_name': 'DNA', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004247', 'descriptor_name': 'DNA', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058990', 'descriptor_name': 'Molecular Targeted Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020125', 'descriptor_name': 'Mutation, Missense', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020125', 'descriptor_name': 'Mutation, Missense', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D064129', 'descriptor_name': 'Prostatic Neoplasms, Castration-Resistant', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/2159-8290.cd-13-0226', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2486275289', 'display_name': 'Cancer Discovery', 'issn_l': '2159-8274', 'issn': ['2159-8274', '2159-8290'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/2159-8290.22530719', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legend_Tables_1_-_6_from_A_Clinically_Relevant_Androgen_Receptor_Mutation_Confers_Resistance_to_Second-Generation_Antiandrogens_Enzalutamide_and_ARN-509/22530719/1/files/39993845.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/2159-8290.22530722', 'pdf_url': 'https://aacr.figshare.com/ndownloader/files/39993848', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23779130', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/2159-8290.cd-13-0226', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2486275289', 'display_name': 'Cancer Discovery', 'issn_l': '2159-8274', 'issn': ['2159-8274', '2159-8290'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 30, 'referenced_works': ['https://openalex.org/W1816722347', 'https://openalex.org/W1966996152', 'https://openalex.org/W1982813442', 'https://openalex.org/W1985580668', 'https://openalex.org/W1999614615', 'https://openalex.org/W2003955264', 'https://openalex.org/W2024304133', 'https://openalex.org/W2041142042', 'https://openalex.org/W2043848949', 'https://openalex.org/W2051025382', 'https://openalex.org/W2066570340', 'https://openalex.org/W2074631079', 'https://openalex.org/W2078400569', 'https://openalex.org/W2084637523', 'https://openalex.org/W2105129152', 'https://openalex.org/W2113031878', 'https://openalex.org/W2117753040', 'https://openalex.org/W2119504728', 'https://openalex.org/W2123853229', 'https://openalex.org/W2130875528', 'https://openalex.org/W2134988422', 'https://openalex.org/W2148643283', 'https://openalex.org/W2156034684', 'https://openalex.org/W2164092182', 'https://openalex.org/W2168011358', 'https://openalex.org/W2468031161', 'https://openalex.org/W2603493263', 'https://openalex.org/W2613104851', 'https://openalex.org/W4235642752', 'https://openalex.org/W4246249043'], 'related_works': ['https://openalex.org/W4293281514', 'https://openalex.org/W4250573295', 'https://openalex.org/W2155957997', 'https://openalex.org/W2082541377', 'https://openalex.org/W2075926109', 'https://openalex.org/W2002404380', 'https://openalex.org/W1993338898', 'https://openalex.org/W1969896443', 'https://openalex.org/W1966952374', 'https://openalex.org/W1848444843'], 'abstract_inverted_index': {'Despite': [0], 'the': [1, 6, 23, 59, 63, 91, 132, 136, 143, 177], 'impressive': [2], 'clinical': [3], 'activity': [4, 51], 'of': [5, 43, 62, 85, 109, 117, 135, 152, 181], 'second-generation': [7, 118, 144], 'antiandrogens': [8, 145, 183], 'enzalutamide': [9, 48, 77, 146], 'and': [10, 31, 38, 47, 76, 81, 147, 155, 158, 179], 'ARN-509': [11, 37, 46, 75, 148], 'in': [12, 58, 78, 79, 82, 97, 131, 149, 161], 'patients': [13, 102, 166], 'with': [14, 103, 126, 167, 188], 'prostate': [15, 87, 156], 'cancer,': [16], 'acquired': [17, 27], 'resistance': [18, 73, 120, 141], 'invariably': [19], 'emerges.': [20], 'To': [21], 'identify': [22], 'molecular': [24], 'mechanisms': [25], 'underlying': [26], 'resistance,': [28], 'we': [29], 'developed': [30], 'characterized': [32], 'cell': [33, 44], 'lines': [34], 'resistant': [35], 'to': [36, 53, 71, 74, 142, 193], 'enzalutamide.': [39], 'In': [40], 'a': [41, 54, 113, 173, 189], 'subset': [42], 'lines,': [45], 'exhibit': [49], 'agonist': [50], 'due': [52], 'missense': [55, 129], 'mutation': [56, 130], '(F876L)': [57], 'ligand-binding': [60, 133], 'domain': [61, 134], 'androgen': [64, 137], 'receptor': [65, 138], '(AR).': [66], 'AR': [67, 92, 110, 153], 'F876L': [68, 93, 111, 139], 'is': [69, 95, 112, 159], 'sufficient': [70], 'confer': [72], 'vitro': [80], 'vivo': [83], 'models': [84, 151], 'castration-resistant': [86], 'cancer': [88, 157], '(CRPC).': [89], 'Importantly,': [90], 'mutant': [94], 'detected': [96, 160], 'plasma': [98, 162], 'DNA': [99, 163], 'from': [100, 164], 'ARN-509-treated': [101, 165], 'progressive': [104, 168], 'CRPC.': [105], 'Thus,': [106], 'selective': [107], 'outgrowth': [108], 'clinically': [114], 'relevant': [115], 'mechanism': [116], 'antiandrogen': [119], 'that': [121, 184], 'can': [122], 'potentially': [123], 'be': [124, 186], 'targeted': [125], 'next-generation': [127, 182], 'antiandrogens.A': [128], 'confers': [140], 'preclinical': [150], 'function': [154], 'disease.': [169], 'These': [170], 'results': [171], 'chart': [172], 'new': [174], 'path': [175], 'for': [176], 'discovery': [178], 'development': [180], 'could': [185], 'coupled': [187], 'blood-based': [190], 'companion': [191], 'diagnostic': [192], 'guide': [194], 'treatment': [195], 'decisions.': [196]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2121846636', 'counts_by_year': [{'year': 2024, 'cited_by_count': 34}, {'year': 2023, 'cited_by_count': 28}, {'year': 2022, 'cited_by_count': 37}, {'year': 2021, 'cited_by_count': 49}, {'year': 2020, 'cited_by_count': 52}, {'year': 2019, 'cited_by_count': 51}, {'year': 2018, 'cited_by_count': 44}, {'year': 2017, 'cited_by_count': 48}, {'year': 2016, 'cited_by_count': 68}, {'year': 2015, 'cited_by_count': 72}, {'year': 2014, 'cited_by_count': 64}, {'year': 2013, 'cited_by_count': 12}], 'updated_date': '2024-12-20T18:46:34.939732', 'created_date': '2016-06-24'}